Florida Hospital Transplant Institute

Orlando, Florida 32804

0 studies enrolling now · 6 studies all time

What they study most

Acute Antibody-Mediated Rejection (AMR), Decompensated Cirrhosis, Heart Failure, Hepatitis C Infection, Hepatitis, Viral, Human, Hepatocellular Carcinoma, Iron-deficiency, Liver Cirrhosis, Non Alcoholic Steatohepatitis (NASH), Nonalcoholic Steatohepatitis, Viruses

Studies at this site

• Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
• Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed
• A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant — Stopped early
• Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis — Status unconfirmed
• Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. — Completed